A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota

BACKGROUND: Successful chemoprevention or chemotherapy is achieved through targeted delivery of prophylactic agents during initial phases of carcinogenesis or therapeutic agents to malignant tumors. Bacteria can be used as anticancer agents, but efforts to utilize attenuated pathogenic bacteria suff...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Yusook, Ryu, Yongku, An, Byung Chull, Yoon, Yeo-Sang, Choi, Oksik, Kim, Tai Yeub, Yoon, Jaekyung, Ahn, Jun Young, Park, Ho Jin, Kwon, Soon-Kyeong, Kim, Jihyun F., Chung, Myung Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157686/
https://www.ncbi.nlm.nih.gov/pubmed/34039418
http://dx.doi.org/10.1186/s40168-021-01071-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157686/
https://www.ncbi.nlm.nih.gov/pubmed/34039418
http://dx.doi.org/10.1186/s40168-021-01071-4

Ejemplares similares